HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2285-2289

  Mardente, Stefania ^a   Mari, Emanuela ^a   Consorti, Fabrizio ^a   Di Gioia, Cira ^a   Negri, Rodolfo ^b   Etna, Marilena ^b   Zicari, Alessandra ^a   Antonaci, Alfredo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chemotaxis; High mobility group box 1 protein; MicroRNAs; Papillary cancer; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HIGH MOBILITY GROUP B1 PROTEIN; MICRORNA 221; MICRORNA 222; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TOLL LIKE RECEPTOR;

ADULT; AGED; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE REGULATION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; THYROID PAPILLARY CARCINOMA; TUMOR MICROENVIRONMENT;

ADULT; AGED; CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HMGB1 PROTEIN; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PTEN PHOSPHOHYDROLASE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

EID: 84868126751     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2058     Document Type: Conference Paper

References (23)

1. Mardente S, Zicari A, Consorti F, Mari E, Di Vito M, Leopizzi M, Della Rocca C and Antonaci A: Cross-talk between NO and HMGB1 in limphocytic thyroiditis and papillary thyroid cancer. Oncol Rep 24:1455-1461, 2010.
2. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-κB funtions as a tumor promoter in inflammation-associated cancer. Nature 431:261-266, 2004.
3. Mardente S, Lenti L, Lococo E, Consorti F, Della Rocca C, Romeo S, Misasi R and Antonaci A: Phenotypic and functional characterization of lymphocytes in autoimmune thyroiditis and in papillary carcinoma. Anticancer Res 25:2483-2488, 2005. (Pubitemid 41044736)
4. Van Beijnum JR, Buurman WA and Griffioen AW: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11:91-99, 2008.
5. Galardi S, Mercatelli N, Farace MG and Ciafrè SA: NF-κB and c-Jun. induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res 39:3892-3902, 2011.
6. Palumbo R, De Marchis F, Pusterla T, Conti A, Alessio M and Bianchi ME: Src family kinases are necessary for cell migration induced by extracelllular HMGB1. J Neurooncol 86:617-623, 2009.
7. Toure F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, Vitry F, Chanard J, Gillery P and Rieu P: Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J 416:255-261, 2008.
8. Kim JY, Park HK, Yoon JS, Kim SJ, Kim ES, Ahn KS, Kim DS, Yoon SS, Kim BK and Lee YY: Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways. Int J Oncol 33:493-501, 2008.
9. Maehama T and Dixon JE: PTEN: a tumour suppressor that functions asa phospholipid phosphatase. Trends Cell Biol 9:125-128, 1999. (Pubitemid 29161437)
10. Si ML, Zhu S, Wu H, Wu F and Mo YY: miR-21-mediated tumor growth. Oncogene 26:2799-2803, 2007. (Pubitemid 46663837)
11. Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682-688, 2007. (Pubitemid 47552092)
12. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136:215-233, 2009.
13. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM and De La Chapelle A: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:1975-1980, 2005.
14. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM and Fusco A: MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14:791-798, 2007. (Pubitemid 350074067)
15. Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 10:367, 2010.
16. Fabien N, Fusco A, Santoro M, Barbier Y, Dubois PM and Paulin C: Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer 15:2206-2212, 1994. (Pubitemid 24107978)
17. Hummel R, Hussey DJ and Haier J: MicroRNAs: predictors and modifiers of chemo-and radiotherapy in different tumour types. Eur J Cancer 46:298-311, 2010.
18. Cully M, You H, Levine AJ and Mak TW: Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184-192 2006. (Pubitemid 43292562)
19. Li Q, Li M, Wang YL, Fauzee NJ, Yang Y, Pan J, Yang L and Lazar A: RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway. Cell Physiol Biochem 29:361-372, 2012.
20. Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB and Wong N: MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res 16:867-875, 2010.
21. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, Rossi JJ and Natarajan R: TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11:881-889, 2009.
22. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129, 2006. (Pubitemid 43816961)
23. Vincenti S. Brillante N, Lanza V, Bozzoni I, Presutti C, Chiani F, Etna MP and Negri R: HUVEC respond to radiation by inducing the expression of pro-angiogenic microRNAs. Radiat Res 175:535-546, 2011.